Abstract:Objective:To explore the genetic mutation, clinical characteristics, diagnosis and treatment of patients with hereditary coagulation factor FⅪ deficiency.Methods:On August 10 and October 30, 2020, two patients with hereditary FⅪ deficiency who were admitted at Department of Hematology, West China Hospital of Sichuan University were selected as research subjects. Patients 1 and 2 were numbered according to visiting time. Diagnosis was made according to coagulation function test and results of gene sequencing F11 gene.Clinical observation or symptomatic treatment were performed according to clinical bleeding symptom and severity. Novel mutations were confirmed by retrieving Human Gene Mutation database (HGMD), Single Nucleotide Polymorphism Database (dbSNP) and PubMed database. Pathogenicity of the novel missense mutation was predicted by computational software of Mutation Taster, Polyphen-2, and PROVEAN. Follow-up of patients was conducted until February 28, 2021. Clinical manifestations and process of diagnosis and treatment of two patients were analyzed retrospectively. China National Knowledge Infrastructure database, Wanfang Data Knowledge Service Platform, PubMed database were searched for the same and similar case reports as F11 genetic mutation in this study.Retrieval time was from database inception to February 28, 2021. Types of genetic mutations and clinical manifestations related to patients in this study were summarized.This study meeted the requirements of the World Medical Association Declaration of Helsinki revised in 2013. Informed consent of patients was obtained from pateints. Results:① Results of medical history: patient 1, a 24 years old man, was admitted due to " hematoma after soft tissue trauma in left thigh and preoperative examination revealed coagulation dysfunction" and did not complain of significant discomfort.Patient 2, a 32 years old woman, was admitted due to " pre-pregnancy physical examination found prolonged activated partial thromboplastin time (APTT)" and complained of occasional ecchymosis.② Results of related laboratory examination: APTT, prothrombin time (PT) and FⅪ activity (FⅪ∶C) of patient 1 were 97.9 s, 11.9 s and 0.6%, while patient 2 were 95.4 s, 12.5 s, and 1.2%, respectively. ③ Results of DNA sequencing: patient 1 had a compound heterozygous missense mutation of F11 gene at c. 149G>T(p.Cys50Phe) and c. 1204C>T (p.Gln402Ter), while patient 2 had a homozygous deletion of F11 gene at c. 1058delA (p.Asn353ThrfsTer18). ④ F11 gene missense mutation at c. 149G>T(p.Cys50Phe) and deletion c. 1058delA(p.Asn353ThrfsTer18) were two novel mutations and both were pathogenic.⑤Results of treatment and follow-up: two patients received clinical observation. At end of follow-up, general condition of the patients was good. ⑥ Results of literatures review: among 10 patients reported in 6 relevant literatures, there were 1, 3, 6 patients caused by heterozygous nonsense mutation of c. 1204C>T(p.Gln402Ter), nonsense mutation of c. 1202C>T(p.Trp401Ter) adjacent to c. 1204C>T (p.Gln402Ter) and missense mutations near the position of c. 149G>T(p.Cys50Phe), respectively. Conclusions:Two novel mutations of hereditary FⅪ deficiency namely a missense mutation at c. 149G>T(p.Cys50Phe) and a deletion at c. 1058delA(p.Asn353ThrfsTer18) of F11 gene were reported in this study. Both of the two mutations related to decrease of FⅪ∶C.

Study on the Molecular Mechanism of Two New Mutations Causing Haemophilia B

An Intronic Mutation C.6430-3C>g in the F8 Gene Causes Splicing Efficiency and Premature Termination in Hemophilia A

Genetic analysis of patients with hereditary coagulation factor Ⅺ deficiency and literatures review

Studies on the mechanism of the Arg327Ile mutant causing defect in the function of factor Ⅸ

[The molecular mechanism of haemophilia B caused by the Arg327Ile novel mutation in FIX gene in vitro expression].

Study on the Mutation of FⅨ Gene in 31 Patients with Type B Hemophilia

Factor Ⅷ A1 domain substitution His99Arg resulting in super-instability of factor Ⅷ in a mild hemophilia A patient

Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM(-)) and G1948D (CRM(r))

Molecular pathogenesis of two novel splice site mutations of F8 in hemophilia A

Detection of Factor Ⅸ gene Mutation in Paitients with Hemophilia B by DNA Sequencing

Characterization of missense mutations in the signal peptide and propeptide of FIX in hemophilia B by a cell-based assay

Identification of Mutations in the F8 and F9 Gene in Families with Haemophilia Using Targeted High-Throughput Sequencing.

A Strategy for the Molecular Diagnosis in Hemophilia A in Chinese Population

Characterization of Genetic Defects in Casese of Haemophilia A of Chinese Origin

Structural and Functional Exploration of Three Newly Identified Coagulation Factor IX Mutations in Chinese Hemophilia B Patients

Molecular characterisation of Tyr530Ser and IVS16–1G>T mutations causing severe factor V deficiency:

Identification of Gene Mutations in Two Coagulation Factor V Deficiency Patients

The binding mechanisms of F Ⅷ Trp1707Ser mutation-associated inhibitor

Gene Analysis and Pathogenesis in 40 Patients with Hemophilia B

The molecular mechanisms of inherited factor Ⅻ deficiency in two unrelated families

Study on the molecular mechanism of the inherited factor X deficiency in three unrelated families